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Chronic alcohol abuse results in morphological, metabolic, and functional brain damage which may, to some
extent, be reversible with early effects upon abstinence. Although morphometric, spectroscopic, and neuro-
psychological indicators of cerebral regeneration have been described previously, the overall amount and
spatial preference of early brain recovery attained by abstinence and its associations with other indicators
of regeneration are not well established.We investigated global and local brain volume changes in a longitudinal
two-timepoint study with T1-weighted MRI at admission and after short-term (6–7 weeks) sobriety follow-up in
15 uncomplicated, recently detoxified alcoholics. Volumetric brain gain was related to metabolic and neuro-
psychological recovery. On admission and after short-term abstinence, structural image evaluation using
normalization of atrophy (SIENA), its voxelwise statistical extension to multiple subjects, proton MR spectro-
scopy (1H-MRS), and neuropsychological tests were applied. Upon short-term sobriety, 1H-MRS levels of
cerebellar choline and frontomesial N-acetylaspartate (NAA) were significantly augmented. Automatically
detected global brain volume gain amounted to nearly two per cent on average and was spatially significant
around the superior vermis, perimesencephalic, periventricular and frontal brain edges. It correlated positively
with the percentages of cerebellar and frontomesial choline increase, as detected by 1H-MRS. Moreover,
frontomesial NAA gains were associated with improved performance on the d2-test of attention. In 10 age-
and gender-matched healthy control subjects, no significant brain volume or metabolite changes were
observed. Although cerebral osmotic regulations may occur initially upon sobriety, significant increases of
cerebellar choline and frontomesial NAA levels detected at stable brain water integrals and creatine concen-
trations, serum electrolytes and red blood cell indices in our patient sample suggest that early brain recovery
through abstinence does not simply reflect rehydration. Instead, even the adult human brain and particularly
its white matter seems to possess genuine capabilities for regrowth. Our findings emphasize metabolic as well
as regionally distinctmorphological capacities for partial brain recovery from toxic insults of chronic alcoholism
and substantiate early measurable benefits of therapeutic sobriety. Further understanding of the precise
mechanisms of this recovery may become a valuable model of brain regeneration with relevance for other
disorders.
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Introduction
Chronic alcoholism is a major source for the morbidity and
mortality of a large variety of diseases worldwide and can
cause, among others, substantial cerebral damage. The
existence of irreversible cerebral atrophy and dementia
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purely related to the toxic effects of alcohol and not to
secondary disorders (such as nutritional Wernicke’s ence-
phalopathy and Korsakoff’s amnestic syndrome) has been
disputed (Victor et al., 1985). Nevertheless, it is generally
agreed that chronic alcoholism results in grey and white
matter brain injury which is neuropathologically detectable
and accompanied by brain shrinkage, reductions of neuronal
and glial markers as well as neuropsychological impairments
(Kril et al., 1997; Harper et al., 2003).
Previous comparisons of alcoholic versus healthy subjects
or non-heavily drinking controls by proton magnetic
resonance spectroscopy (1H-MRS) have revealed reduced
levels of brain N-acetylaspartate (NAA) in most (Fein et al.,
1994; Jagannathan et al., 1996; Seitz et al., 1999; Bendszus
et al., 2001; Schweinsburg et al., 2001; 2003; Bloomer et al.,
2004; Durazzo et al., 2004; Meyerhoff et al., 2004; Viola et al.,
2004) but not all investigations and brain regions studied
(Schweinsburg et al., 2000; Parks et al., 2002; Ende et al.,
2005; Mason et al., 2006). Similarly, lowered levels of choline
have been detected (Jagannathan et al., 1996; Seitz et al.,
1999; Bloomer et al., 2004; Viola et al., 2004; Ende et al.,
2005; Mason et al., 2006), although this finding seems even
more ambiguous (Schweinsburg et al., 2000, 2001, 2003) and
dependent on localization (Bendszus et al., 2001; Parks et al.,
2002). Shifts between different choline containing com-
pounds may contribute to these heterogeneous results (Lee
et al., 2003). Spectroscopic elevations of inositol compounds
(Schweinsburg et al., 2000, 2001; Viola et al., 2004) due to
alcohol toxicity and deviations of other metabolites such
as g-aminobutyric acid (Behar et al., 1999), glutamate, and
glutamine have been reported but as yet these are still
conflicting (Seitz et al., 1999; Braunova et al., 2000; Parks
et al., 2002; Meyerhoff et al., 2004), related to comorbidities
such as nicotine abuse (Mason et al., 2006), medical
complications such as hepatic failure (Mesisca and Ross,
quoted in Mason et al., 2005) or just the timepoint studied
(Mason et al., 2003) and mostly difficult to detect reliably
at conventional field strength and with appropriate signal-
to-noise (S/N) ratios. Obviously, cross-sectional differences
may depend on the tissue compartments and brain region
studied as well as on gender (Schweinsburg et al., 2003),
age, and concomitant complications such as clinical
encephalopathy and metabolic alterations. In general, they
are neither specific nor sufficient to reliably discriminate
alcoholics from controls, and to separate potential pure
alcoholic brain damage from secondary medical complica-
tions, the necessity to discriminate between cases of
uncomplicated primary alcohol dependence and those
suffering from secondary or concomitant diseases has been
strongly emphasized (Victor et al., 1985; Kril et al., 1997;
Harper et al., 2003).
Notably, cerebral volume loss, metabolic and neuropsy-
chological impairments associated with chronic alcoholism
may be in part reversible, even (and possibly primarily)
during early stages of abstinence (Meyerhoff, quoted
in Mason et al., 2005; Gazdzinski et al., 2005a). Upon
longitudinal studies with sobriety, evidence for recovering
NAA (Bendszus et al., 2001; Parks et al., 2002; Durazzo et al.,
2006) as well as choline (Bendszus et al., 2001; Ende et al.,
2005; Durazzo et al., 2006) levels has emerged, albeit
somewhat equivocally with respect to other data (Martin
et al., 1995; Schweinsburg et al., 2000; O’Neill et al., 2001;
Ende et al., 2005). Nicotine abuse is strongly suspected to
exacerbate brain NAA and choline loss in alcoholics
(Durazzo et al., 2004) and to constrain their recovery upon
abstinence (Durazzo et al., 2006). Regression of ventricular
enlargement and sulcal widening upon abstinence has been
reported more than two and a half decades ago (Carlen et al.,
1978; Lishman, 1981) and substantiated thereafter (Schroth
et al., 1988; Zipursky et al., 1989; Bendszus et al., 2001). This
brain volume regain upon abstinence indicates that cerebral
tissue shrinking is at least not entirely due to irreversible
brain atrophy. Although there is some evidence that
morphological restitution should not only be attributed
to rehydration (Mander et al., 1989; Trabert et al., 1995;
Schroth et al., 1998), the overall brain volume gain attained
early upon abstinence, its localization and association with
metabolic indicators for recovery from alcoholic brain
damage as well as factors presumably limiting regeneration
such as duration of dependence, are not satisfactorily
established. The objective of the investigation reported
here was the prospective, and longitudinal evaluation of
morphometric, spectroscopic and neuropsychological
effects of short-term sobriety in uncomplicated, not
dehydrated or heavily smoking alcoholics without clinical
encephalopathy.
Material and methods
The investigation presented was designed as a prospective
longitudinal study collecting MR morphometry, 1H-MRS, and
neuropsychological data as well as blood samples from alcohol-
dependent patients and, in part, healthy controls at two timepoints,
i.e. at enrolment and upon a 6–7 weeks sobriety follow-up.
Subjects
24 patients (age 41 6 8; 29 to 58 years; 16 male, 8 female) afflicted
with primary alcohol dependence according to DSM-IV and ICD-
10 criteria and admitted to a specialized inpatient treatment unit
were enrolled into the study. Diagnosis was established by a trained
interviewer (G.A.W.) using the Semi-Structured Assessment for the
Genetics of Alcoholism (Buchholz et al., 1994). Thereby, personal
history of alcohol and drug abuse, occurrence of major alcohol-
related life problems, and demographic information were recorded.
Age for inclusion was set between 18 and 60 years, and active
alcohol dependence (12 6 7; 3 to 25 years duration) had to have
lasted for the past 3 years or longer without previous full or partial
remissions according to DSM-IV criteria. Alcohol consumption
was estimated by (i) the number of days spent with active drinking
per month (i.e. frequency of drinking), (ii) the average number of
standard drinks containing 10 g of ethanol per drinking day
(quantity of drinking), (iii) the maximum number of standard
drinks consumed per drinking day, and (iv) the total number of
standard drinks during the last 3 months before admission.
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Based upon multiaxial assessment, exclusion criteria were the
following: a lifetime diagnostic history of any other psychiatric axis
I or II disorder except alcohol dependence, previous alcohol
withdrawal, nicotine abuse above an equivalent of 10 cigarettes per
day, and presence of any other general medical condition or axis III
illness as well as therapeutic need for psychoactive medication.
Therefore, patients suffering from intoxication delirium upon
admission, withdrawal delirium during actual detoxification,
substance-induced persisting amnestic disorder (Korsakoff’s
syndrome), overt Wernicke’s encephalopathy, central pontine or
extrapontine myelinolysis (Machiafava-Bignami’s disease), hepatic
encephalopathy, or other alcohol-induced disorders were not
eligible for the study. Initial MR morphometric, spectroscopic,
and neuropsychological exams were carried out within the first
four (2 6 1; 1 to 4) days upon admission and within the first week
after the last drink reported (3 6 1; 2 to 7 days) when there was no
evidence of persisting withdrawal and no blood alcohol was
detected. Severity of withdrawal was monitored by brief clinical
examination and heart rate as well as blood pressure measure-
ments every 8 h for the first week upon admission. Abstinence was
monitored carefully on a daily basis, and no psychoactive
medication was administered. Upon short-term abstinence (i.e.
38 6 3; 35 to 42 days after the initial exam), nine patients were
non-compliant with their abstinence treatment (n = 8) or study
enrolment (n = 1) leaving a total of 15 patients (aged 42 6 8;
31 to 58 years; 10 male, 5 female) in the follow-up sample. Up to
this timepoint, these patients had successfully maintained sobriety
without evidence for prolonged or late withdrawal upon
detoxification. There was no difference in gender, age or duration
of dependence between compliant and non-compliant patients
(Pcorrected > 0.46, np = 3; Fisher’s exact test, U-test). Furthermore,
males were not significantly overrepresented in our final patient
follow-up sample (n = 15), and these remaining men and women
did not differ with regard to age (males: 39 6 8; 31 to 58, females:
47 6 6; 36 to 53 years) or duration of dependence (males: 12 6 7;
3 to 23, females: 12 6 7; 6 to 25 years; Pcorrected > 0.21, np = 3; test
of equal or given proportions test, U-test).
For control purposes, 10 healthy volunteers (47 6 7; 30 to 55
years; 6 male, 4 female) were recruited via local newspaper
advertisements. Gender and age distribution of the volunteers were
matched to the patients studied, and the interval between their
initial and follow-up exam (42 6 7; 34 to 60 days) was not
significantly different from the patients (Pcorrected > 0.24, np = 3;
Fisher’s exact test, U-test). Detailed screening excluded any present
or past alcohol- or other substance-related disorder as well as any
relevant general medical condition. This was supported by normal
CAGE questionnaire ratings (Mayfield et al., 1974) and blood
samples drawn which were analysed for red blood cell (RBC)
indices, haematocrit, carbohydrate-deficient transferrin (CDT),
and g-glutamyl-transferase (GGT) values.
All subjects provided written informed consent, and the study
was approved by the local ethics committee.
MR morphometry (SIENA and its voxelwise
extension across subjects)
All MR measurements were performed on a 1.5 tesla (63.7 MHz)
Magnetom Vision scanner (Siemens Medical, Erlangen, Germany)
running on Numaris3 (VA33D) with a circularly polarized
transceiver head coil. T2-weighted TRUe Fast Imaging with steady-
state precession spin echo (SE) localizers [TR/TE = 6.08/3.04 ms,
flip angle (FA) = 70] of the whole brain were acquired in axial,
coronal, and sagittal 5 mm planes. Additionally, proton density
(PD)- and T2-weighted SE sequences [TR/TE = 2100/20 and
80 ms, FA = 12, phase-encoding (PhE) = left-to-right, field of view
(FoV) = 256 · 256 mm2, 19 slices, slice thickness = 6 mm, 20%
gap] centred and angulated parallel to the anterior commissure–
posterior commissure line were used for neuroradiological screening.
For MR morphometry, sagittally oriented T1-weighted
magnetization-prepared rapid gradient echo (MP-RAGE) (i.e.
turbo fast low angle shot) pulse sequences (TR/TE = 9.70/4.0 ms,
FA = 12, PhE = posterior-to-anterior, FoV = 256 · 256 mm2, slab
thickness = 186 mm) were recorded covering the entire head at an
isotropic voxel size of 1 mm3. Axial PD-/T2-weighted and coronal
T1-weighted reconstructions assured absence of gross parenchymal
signal alterations, poliohaemorrhagic lesions, and overt mammil-
lary body atrophy.
Structural image processing and data analysis was performed
using FSL (FMRIB Software Library release 3.3, http://www.fmrib.
ox.ac.uk/fsl; Smith et al., 2004) by a single experienced neuro-
radiology resident (A.J.B.) blinded to patient and control data at
the interactive stages. Images were loaded into FSLView, and
myelencephalon and medulla spinalis were edited out, by hand,
below the level of the pons at the medullopontine sulcus (see Fig. 1).
Then, images were submitted to structural image evaluation using
normalization of atrophy (SIENA version 2.4, part of FSL). To
achieve optimal brain/non-brain separation for the individuals
examined, thresholds for brain extraction were adjusted from
0.4 to 0.6, and optional standard space brain masking was used.
To avoid the introduction of any systematic longitudinal bias,
however, both options were fixed for any given subject. External
skull border estimates were obtained. Brain-extracted images were
then reinspected, and residual non-brain tissue (such as nasal or
dural sinuses, skull and clivus, in particular) was segmented out by
hand in FSLView. These cleaned brain images (with non-brain
tissue, medulla spinalis and oblongata removed) were then fed back
into SIENA (Smith et al., 2001, 2002) to estimate the final two-
timepoint percentage brain volume change (PBVC). SIENA starts
by extracting brain and skull images from the two-timepoint
whole-head input data (Smith, 2002). The two brain images are
then aligned to each other (Jenkinson and Smith, 2001, Jenkinson
et al., 2002) using the skull images to constrain the registration
scaling; both brain images are resampled into the space halfway
between the two. Next, tissue-type segmentation is carried out
(Zhang et al., 2001) combining grey and white matter estimates
into a single class in order to find brain/non-brain edge points,
and then perpendicular edge displacement (between the two
timepoints) is estimated at these edge points. Finally, the mean
edge displacement is converted into a (global) estimate of PBVC
between the two timepoints.
To allow for a voxelwise statistical extension to multiple subjects,
standardized cerebral edge flow images were obtained (De Stefano
et al., 2003). The subject-specific edge flow images (which encode
amount and direction of perpendicular local brain edge motion
between successive scans) were spatially dilated, affine transformed
to standard space by FLIRT (FMRIB’s Linear Image Registration
Tool version 5.4.2), masked with a standard space brain edge
image, smoothed by an isotropic Gaussian kernel (s = 5 mm), and
remasked. This produced cerebral edge flow images in standard
space which were submitted to voxelwise statistical analysis. For
investigation of the patients, standard space was defined by a skull-
stripped custom template (see Fig. 1 for a patient background
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image in standard space). It was constructed from the sum of the
skull-stripped initial MP-RAGE scans of all 24 patients studied
which were co-registered by full affine transformations to the
MNI152 template using FLIRT and smoothed by an isotropic
Gaussian kernel (s = 3 mm). To optimize the edge mask used, a
group-specific brain edge image was generated for the patients
(according to FSL’s make_edges script).
MR spectroscopy (1H-MRS)
Localized 1H-MRS consisted of single voxel spectroscopy (SVS)
measurements by a point-resolved spectroscopy (PRESS) SE
sequence at TE = 135 ms (TR = 1500 ms, vector size 1024). For
every voxel, two spectra with and without CHEmical-Shift Selective
water suppression were obtained (128 versus 16 acquisitions). Fixed
scanner calibration was confirmed by external in vitro standards.
Isotropic voxels (20 · 20 · 20 mm3) were placed infratentorially in
the left cerebellar hemisphere, whereas voxels of 30 · 40 · 20 mm3
were used on the supratentorial level for the mesial frontal lobes.
Reproducible positioning was achieved as described previously by
setting the cerebellar voxel with its medial edge in the left cerebellar
hemisphere, close to the fourth ventricle, and with its superior edge
below the tentorium, and by placing the frontal voxel with its
inferior edge at the callosomarginal sulci and with its posterior edge
at the central sulci (Bendszus et al., 2001).
For spectral analysis, the user-independent frequency domain-
fitting routine by LCModel (version 6.1–4/LCMgui version
2.1–4; http://s-provencher.com/pages/lcmodel.shtml) was used.
Eddy current correction was performed in the time domain by
the voxels unsuppressed water reference Free Induction Decay
dividing the water-suppressed signal by the phase factor of the
water signal for each data point (Klose, 1990). Water integrals were
obtained by extracting areas of unsuppressed water peaks from
LCModel’s detailed print output. S/N values were estimated by the
ratio of the maximum in the spectrum-minus-baseline over the
default analysis window to twice the root-mean-square residuals.
Metabolite quantifications of NAA, choline, creatine, myo-inositol,
and ethanol were based upon calibration measurements. Other
metabolites (i.e. N-acetylaspartyl-glutamate, scyllo-inositol. gluta-
mate, glutamine, g-aminobutyric acid, macromolecules, phospho-
choline, and glycerophosphocholine) were not considered in the
analyses for these are either hard to resolve at 1.5 T with the
particular PRESS sequence employed and/or because Crame´r-Rao
lower bounds were not consistently <50%. All metabolite
quantifications were transformed into relative percentages of
change adjusting for mean local brain volume change (based on
Fig. 1 Significant morphometric edge flow indicating early brain regeneration through abstinence from alcoholism (voxelwise
non-parametric SIENA statistics at Pcorrected < 0.05; n = 15; overlay onto custom template space on skull-stripped single-patient
MP-RAGE background for preservation of sulci and gyration; display in ‘radiological convention’ with left projected on right image side).
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individual flow images masked with jointly co-registered spectro-
scopy voxels) at short-term abstinence of the 15 patients studied
twice and at follow-up of the 10 volunteers re-examined. The
correction for within spectroscopy voxel brain volume change was
made to exclude confounding effects by partial voluming, i.e. that a
local brain volume difference itself propagates into metabolite
changes.
Neuropsychological assessment
Neuropsychological performance of the patients was assessed in
the areas of attention and concentration (d2-test), long-term
memory (Auditory Verbal Learning Test), and non-verbal (Stan-
dard Progressive Matrices) as well as verbal cognitive abilities
(Vocabulary Test) by a single experienced psychologist (H.-G.W.).
Due to its favourable time and compliance requirements, the
d2-test of attention and concentration was applied twice to the
patients, i.e. upon initial examination and after sobriety had been
maintained by short-term abstinence. It is described in more detail
below.
d2-Test of attention. This is a paper and pencil test asking for
prompt detection of three subtly different target stimuli. Subjects
are instructed to mark targets as fast and with as few errors as
possible. Thus, speed and rule compliance are tested under a task-
load condition. By subtracting omission and commission error
count (i.e. the number of missing and false responses) from the
total number of stimuli processed, an overall performance estimate
is obtained. This reflects individual attention span, concentration
ability and coordination. By norm tables of the test manual, it can be
transformed into a standardized performance value (Brickenkamp,
1994). After a brief instruction, the test was administered indivi-
dually within <5 min testing time. The difference of standardized
performance values upon short-term abstinence was used to
indicate d2-test performance changes. The internal test–retest
reliability of the d2-test of attention has been proven to be extra-
ordinary high and in the range of 0.95 to 0.98 for all parameters. Its
criterion, construct, and predictive validity has been documented,
and test values have been shown to be stable over an extended
period of up to 23 months after initial testing.
The other three tests were only administered to the patients
after sobriety had been maintained by short-term abstinence.
Blood alcohol content, red blood cell indices,
serum electrolytes and enzymes
Blood samples (5 ml blood tubes, 5 ml EDTA blood tubes) were
drawn from the patients’ antecubital vein at their admission
and upon short-term abstinence. Healthy volunteers were subjected
to blood test only once at their initial exam. Blood alcohol
content was established in serum samples by headspace gas
chromatography with flame ionization detection yielding values
15% above whole blood alcohol levels. RBC indices, i.e. mean
corpuscular haemoglobin, mean corpuscular haemoglobin concen-
tration, and mean corpuscular volume, were determined along
with haematocrit values by an automated counter employing
the electrical impedance method (Counter S-Plus IV; Beckmann
Coulter, Fullerton, USA). Serum electrolytes, i.e. sodium, potas-
sium, and chloride, were measured by a potentiometric auto-
analyser (Ektachem 700XRC; Eastman Kodak, Rochester, MN,
USA). CDT and GGT were determined by a commercial double
antibody radioimmunoassay kit (CDTect; Axis-Shield PLC, Oslo,
Norway) and enzymatically by a kinetic method (Oy Medix
Biochemica AB; Kauniainen, Finland).
Statistical analysis
Standardized cerebral edge flow images were statistically analysed
by permutation-based, voxelwise non-parametric testing (as
implemented in the randomise tool, part of FSL). The positive
effect of patients’ short-term abstinence and upon follow-up of
controls was modelled in a single condition/single image per
subject, i.e. one sample t-test, type of design. Statistical inference
was based on voxel-level thresholding at corrected P-values of 0.05
(corresponding to family-wise error rates of 5% for exhaustive
inversion permutation distributions) adjusted for multiple com-
parisons across the number of voxels (i.e. number of comparisons
np) within the tailored edge mask in custom template space by
using null distributions of maximum {Pseudo-t}-test statistics
(Nichols and Holmes, 2001). {Pseudo-t}-statistics were computed
with variance regularization by smoothing with an isotropic
Gaussian kernel (s = 5 mm).
For other statistical analysis, the R environment for statistical
computing (R version 2.3.1; R Development Core Team, 2006,
http://www.r-project.org/) was used. Gaussian distribution of data
variables was assessed by Shapiro-Wilk’s test for normality. Based
upon maintaining or rejecting the normality assumption,
parametric or non-parametric tests for establishing differences or
associations were applied as indicated. For Student’s two sample
t-test, variances were estimated separately for both groups, and the
Welch modification to the degrees of freedom was used. For
Mann–Whitney’s U-test, continuity correction was performed for
P-value approximation. Based upon directional assumptions, one-
sided alternative hypotheses were specified for testing final PBVC,
percentage of NAA and choline increase as well as improved d2-test
performance upon short-term abstinence of the patients and their
positive associations. Furthermore, one-tailed tests were applied
for assessing presumably negative correlations of these parameters
with age, duration of alcohol dependence according to DSM-IV
criteria, and the four estimators of alcohol consumption. Linear
regression fitting was plotted with realistic prediction hyperbolas
at a coverage probability of 0.95 (using linesHyperb.lm of the
sfsmics utilities package version 0.95–6 within R). To correlate
d2-test performance changes with final PBVC or percentage of
NAA and choline increase, Kendall’s tau (t) correlation coefficient
was used for considerations of universality and interpretability. For
corrected P-values outside statistical image analysis, multiple
comparison correction was performed according to the lowest
slope method of Benjamini and Hochberg (1995) by controlling the
false discovery rate (using p.adjust within R), which is less stringent
but more sensitive than family-wise error rates. The number
of comparisons corrected for are indicated by np (based on the
particular omnibus null-hypothesis specified appropriately). Sig-
nificances (P < 0.05) and trends (P < 0.10) detected only at
uncorrected levels are conditionally reported.
Results
MR morphometry (SIENA and its
voxelwise extension across subjects)
For the 15 patients studied upon short-term abstinence, final
PBVC automatically determined by SIENA was 1.85 6
1.32% (0.19 to 4.32%). Thus, a significant global volumetric
brain gain was associated with abstinence (Pcorrected = 0.00,
np = 6, t =5.42, df = 14, t-test; Table 1). No gender difference
was observed for the patients’ PBVC (males: 1.98 6 1.52;
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0.19 to 4.32, females: 1.606 0.92; 0.71 to 2.96%; Pcorrected =
0.74, np = 6, t = 0.51, df = 12.25, t-test). Only the patient
with the longest history of alcohol dependence (25 years),
generated a negative final PBVC, 0.19%. Note that this
value is within the magnitude of SIENA’s established
accuracy of 0.20 PBVC error (Smith et al., 2001).
For the 10 control subjects examined twice, PBVC was
0.03 6 0.41% (0.43 to 0.60%). Thus, the healthy subjects
did not show any evidence for a short-term brain volume
change according to SIENA (Pcorrected = 0.91, np = 26, t =
0.16, df = 9, t-test; Table 1). Additionally, no significant
mean group effect of spatial edge movement was detected
for healthy volunteers at Pcorrected < 0.05 (np = 40551, df = 9,
1024 permutations).
Upon short-term abstinence of the patient group,
significant morphometric brain recovery was revealed at
the superior vermis, perimesencephalic, infra- as well as
supratentorial periventricular borders, and, to a lesser extent,
on frontomesial and -orbital edges (Pcorrected < 0.05, np =
41205, df = 14, 32 768 permutations; Fig. 1).
MR spectroscopy (1H-MRS)
LCModel’s analysis delivered appropriate phasing and
frequency assignments. Its results were examined for non-
random residuals as well as baseline fitting. Estimated S/N
values were 86 3 (5 to 12) for infra- and 146 2 (10 to 19; n= 50)
for supratentorial spectra. Cerebellar spectra were,
as expected, of somewhat poorer quality consistently exhibit-
ing less S/N (see Fig. 2) and higher standard deviations even of
the percentages of metabolite change (Table 1). Crame´r-Rao
lower bounds of the major metabolites NAA, choline, and
creatine were <15%. Those of myo-inositol were <40% of the
estimated frontomesial concentrations whereas cerebellar
myo-inositol was in general not very reliably detected
exhibiting Crame´r-Rao lower bounds >50%. Cerebral ethanol
was not detected in any of the spectra of patients or controls.
For control subjects, insignificant metabolite changes upon
follow-up, standard deviations of percentage metabolite
change as well as Crame´r-Rao lower bounds were compatible
with previous reproducibility reports.
PRESS water integrals did not change significantly in
patients upon short-term abstinence (percentage cerebellar
change: 16 8; 22 to 11%, Pcorrected = 0.77, np = 26, t = 0.51;
percentage frontomesial change: 2 6 6; 11 to 15%,
Pcorrected = 0.62, np = 26, t = 1.35; df = 14) or controls upon
follow-up (cerebellar: 36 8;8 to 22%, Pcorrected = 0.62, np =
26, t = 1.32; frontomesial: 1 6 7; 12 to 8%, Pcorrected =
0.77, np = 26, t = 0.48; df = 9; t-tests). In addition, levels
of infra- and supratentorial creatine and myo-inositol
remained constant in patients upon short-term abstinence
as well as in controls upon follow-up (Pcorrected> 0.62, np = 26;
df = 14 and 9, respectively; t-tests). In the patients, percentage
creatine change amounted to 2 6 12% (18 to 28%) on the
infratentorial level and to 2 6 9% (12 to 25%) on the
supratentorial level. In control subjects, percentage creatine
change amounted to 1 6 7% (11 to 13%) on the
infratentorial level and to 1 6 6% (6 to 12%) on the
supratentorial level. For myo-inositol, percentages of
cerebellar and frontomesial change were 2 6 60% (94 to
99%) and 10 6 39% (66 to 95%) in the patients, versus
2 6 53% (93 to 81%) and 6 6 25% (52 to 45%) in
controls. Furthermore, controls did not exhibit any
significant changes of infra- or supratentorial NAA or
choline quantifications (cerebellar NAA change: 0 6 12/18
to 23%, frontomesial NAA change: 1 6 8/13 to 15%,
cerebellar choline change:16 15/32 to 13%, frontomesial
choline change: 3 6 9/13 to 18%; Pcorrected > 0.73, np = 26;
df = 9, t-tests; Table 1). Notably, there were no significant
group differences of infra- or supratentorial NAA, choline,
creatine and myo-inositol quantifications, or water integrals
between patients and controls in their initial exam and upon
follow-up (Pcorrected > 0.94, np = 20; t-tests; data not shown).
Upon short-term abstinence of the patients, cerebellar
choline and frontomesial NAA levels were significantly
augmented by 196 20% (7 to 58%, Pcorrected = 0.00, np = 6,
t = 3.74) and 116 15% (17 to 36%, Pcorrected = 0.01, np = 6,
Table 1 Morphometric brain volume (SIENA), spectroscopic (PRESS) and neuropsychological changes of short-term
abstinent alcoholics and control subjects
Method Parameter Alcohol-dependent patients upon
short-term abstinence (n = 15)
Non-alcoholic
control subjects upon
short-term follow-up (n = 10)
SIENA Percentage brain volume change (%) ***1.85 6 1.32†,†† 0.03 6 0.41
1H-MRS PRESS cerebellar **19 6 20† 1 6 15
Percentage choline change (%)
frontomesial 9 6 22†† 3 6 9
cerebellar 10 6 24 0 6 12
Percentage NAA change (%)
frontomesial *11 6 15“ 1 6 8
Neuropsychology d2-test performance change
(standardized units)
·11 6 26“ N.T.
Parameter changes = */**/*** Pcorrected < 0.05/0.01/0.001 (t-tests);
·Pcorrected < 0.05 (U-test); values: mean 6 SD; N.T. = not tested;
Positive correlations: †/†† Pcorrected < 0.01 (Pearson’s),
“Pcorrected = 0.05 (Kendall’s, single outlier of d2-performance change excluded).
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Fig. 2 Representative cerebellar and frontomesial MR 1H-spectra (TR = 1500 ms/TE = 135 ms, PRESS) of a patient selected from our sample
(n = 15) of uncomplicated alcoholics upon short-term abstinence and of a healthy control subject upon follow-up (red: LCModel fit, blue:
baseline; displayed range: 1.00–4.00 p.p.m.).
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t = 2.93), respectively (Table 1). There were strong trends for
supratentorial choline (9 6 22/15 to 61%, Pcorrected = 0.06,
np = 6, t = 1.64) and infratentorial NAA levels (10 6 24/43
to 61%, Pcorrected = 0.06, np = 6, t = 1.68; df = 14, t-tests) to
increase as well. No gender differences were established for
the patients’ percentages of choline or NAA change
upon short-term abstinence (Pcorrected > 0.20, np = 6; df >
5.93, t-tests).
Representative infra- and supratentorial spectra of a
patient selected from our sample of uncomplicated alcoholics
upon short-term abstinence and of a healthy control subject
upon follow-up are shown in Fig. 2. The corresponding
percentages of relative metabolite change (also adjusted for
local brain volume differences) were the following: for the
selected patient—cerebellar: NAA 12%/choline 50%, fron-
tomesial: NAA 10%/choline 41%; for the selected control
subject—cerebellar: NAA 3%/choline 13%, frontomesial:
NAA 2%/choline 18%.
Most notably, final PBVC upon the patients’ short-term
abstinence was strongly and positively correlated with
percentages of choline gain (cerebellar: Pcorrected = 0.00,
np = 4, t = 6.23, r = 0.87, Fig. 3; frontomesial: Pcorrected =
0.00, np = 4, t = 3.86, r = 0.73) but not with percentages
of cerebellar or frontomesial NAA change (Pcorrected > 0.33;
df = 13, Pearson’s product moment correlations; Table 1).
Attenuated frontomesial NAA (Puncorrected = 0.01,
t = 2.53, r = 0.57) and cerebellar choline increases
(Puncorrected = 0.01, t = 2.45, r = 0.56) as well as final
PBVC values (Puncorrected = 0.05, t = 1.78, r = 0.44,
Pearson’s) of patients upon their short-term abstinence were
associated with longer durations of illness at uncorrected
significance levels but these correlations did not survive the
multiple comparison correction (Pcorrected > 0.15, np = 30)
and are only conditionally reported here. There was no
tendency, however, for cerebellar NAA and frontomesial
choline changes at uncorrected or corrected levels to be
negatively correlated with illness duration (Pcorrected > 0.36,
np = 30, Pearson’s). Age and the four estimators of alcohol
consumption did not reveal any significant associations
with PBVC or the percentages of NAA and choline change
on the infra- or supratentorial level (Pcorrected> 0.29, np = 30,
Pearson’s).
Neuropsychological assessment
(d2-test of attention, in particular)
Standardized d2-test performance values of the patients
increased by 11 6 26 units (68 to 39 units, Pcorrected = 0.02,
np = 6, V = 99, U-test) upon short-term abstinence. No
gender difference was detected for the patients’ neuropsy-
chological test improvement (males: 10 6 30; 68 to 39,
females: 13 6 17; 15 to 28 units; Pcorrected = 0.98, np = 6,
W = 25.5, U-test). Increase of standardized d2-performance
was positively associated with the percentage of frontomesial
NAA gain (Pcorrected = 0.05, np = 5, z = 2.25, t = 0.46, odds
ratio of concordant versus discordant change observations
pc/pd = 2.70; Fig. 4; Table 1). At uncorrected levels, there
Fig. 3 Percentages of morphometric brain volume and
spectroscopic cerebellar choline change (adjusted for local
brain volume differences) upon short-term abstinence from
alcoholism (linear regression/95% realistic prediction band,
Pcorrected = 0.00; n = 15).
Fig. 4 Standardized d2-test performance change and spectroscopic
frontomesial NAA change (adjusted for local brain volume
differences) upon short-term abstinence from alcoholism (odds
ratio of concordant versus discordant change observations pc/pd =
2.70, Pcorrected = 0.05; n = 14, one outlier of d2-performance
change = 68 standardized units excluded).
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was also a trend of standardized d2-performance gain to be
correlated with the percentage of cerebellar NAA increase
(Puncorrected = 0.08, z = 1.37, t = 0.28, pc/pd = 1.78) and an
association with the final PBVC (Puncorrected = 0.04, z = 1.87,
t = 0.38, pc/pd = 2.23) but these did not survive the multiple
comparison correction (Pcorrected > 0.10, np = 5) and are
again only conditionally reported. Cerebellar or frontomesial
choline gain were not correlated with standardized
d2-performance increase at uncorrected or corrected sign-
ificance levels (Pcorrected > 0.12, np = 5, Kendall’s rank
correlations, single outlier of d2-performance change = 68
standardized units excluded).
Scores of the other three instruments (Auditory Verbal
Learning Test, Standard Progressive Matrices, Vocabulary
Test) were not associated with percentages of infra- or
supratentorial NAA and choline increase and the final PBVC
(Pcorrected > 0.62, np = 5), or with age, duration of alcohol
dependence and the four estimators of alcohol consumption
(Pcorrected > 0.66, np = 6, Kendall’s).
Blood alcohol, red blood cell indices,
haematocrit, serum electrolytes and
enzymes
Blood samples contained no alcohol in any of the probes
taken from the patients or controls. RBC indices,
haematocrit, serum electrolytes and CDT as well as GGT
values were within laboratory reference limits for patients as
well as controls and exhibited no significant changes
between study entry and upon the patients’ follow-up
(Pcorrected > 0.62, np = 26; t-tests; data not shown).
Discussion
To our knowledge, this is the first study presenting
integrated data on automatically detected global and
regional brain volume regain, spectroscopic, and neuro-
psychological recovery in uncomplicated alcoholics upon
short-term sobriety. Strict exclusion criteria limited the
investigation to not heavily nicotine abusing patients
without previous alcohol withdrawal and requiring no
pharmacological support to achieve their abstinence which
is certainly not typical for alcoholism but avoided interac-
tions with secondary medical illnesses, alcohol withdrawal,
administration of psychoactive medication etc. In fact,
differences between our findings and previously published
reports may arise from variations of the severity of
alcoholism, toxicity and accompanying disorders or abuse
between the actual samples studied. However, our results
support the notion that remarkable morphological, meta-
bolic and functional brain regeneration is not just feigned
by rehydration and can be attained rapidly by abstinence
(Mason et al., 2005).
For morphometry, we used normalized longitudinal
brain change analysis by SIENA which is carried out in
individual subject space and does not rely on grey versus
white matter segmentation. Therefore, it avoids misregistra-
tions into standard space possibly limiting other voxel-based
morphometry approaches (Davatzikos, 2004) and is less
contrast-to-noise dependent. Contrary to previous data on
global brain volume regain upon short-term abstinence,
which were derived by a somewhat similar but more MR
contrast dependent method (Gazdzinski et al., 2005a) or
computed tomography (Mann et al., 2005) but that did not
attempt to control for hydration status, the patients’ mean
PBVC in our study exceeds the brain volume change of 1%
detected by SIENA upon de- and rehydration (Duning et al.,
2005; which is, in fact, in the magnitude of the positive
intercept of the linear regression between global brain
volume gain and rising cerebellar choline upon sobriety; see
Fig. 3). Because we included no heavily nicotine abusing
patients, this may also indicate less brain injury and better
regeneration capacity for this patient population (Gazdzinski
et al., 2005b; Durazzo et al., 2006). Global brain volume
change of control subjects was, on the other hand,
insignificant (Table 1) exhibiting standard deviations of
about twice the measurement error reported for SIENA by a
three-timepoint validation (Smith et al., 2002) and upon
repositioning (Duning et al., 2005). Notably, 93% of our
patients (14 out of 15 cases) achieved pronounced global
brain regain beyond the maximum change (i.e. assuming
null effect, the error spread) of controls, highlighting
SIENA’s discriminative power for the assessment of change.
Novel localization of brain volume changes by SIENA’s
regional extension relies on transformation of individual
edge flow images to standard space which was customized
for the study presented. Because standardized flow images
are limited to an outer edge contour and can not retain the
entire subject-specific sulcation pattern, it is conceivable that
regression of sulcal widening without outer brain edge shifts
has led to a conservative or underestimation of regional (but
not global) brain gain at hemispheric convexities upon
recovery from alcoholism (Fig. 1). However, the spatial
analysis of longitudinal brain volume change employed can
be presumed to be particularly sensitive to ventricular edge
motion. Given that a recent automated, cross-sectional
and segmentation-based study failed to find ventricular
enlargement due to chronic alcoholism (Gazdzinski et al.,
2005b), this is noteworthy and further emphasizes the
advantage of longitudinal morphometry. Our results suggest
that both ventricular volume as well as brainstem atrophy
associated with chronic heavy drinking and cross-sectionally
confirmed by manual morphometry (Bloomer et al., 2004)
can in fact regress upon short-term sobriety of uncom-
plicated alcoholics. Furthermore, longitudinal brain edge
shifts upon recovery at corrected significance levels (tested
non-parametrically to avoid violations of Gaussian random
field assumptions by standardized flow images) included
superior vermical, frontomesial as well as orbitofrontal
edges and were spatially more extensive than the tissue
contractions detected cross-sectionally at uncorrected
significance levels (arguably derived by parametric inference)
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in chronic active heavy compared to light drinkers by
deformation-based morphometry (Cardenas et al., 2005).
For spectroscopy data, relative percentages of metabolite
change were derived and adjusted for within voxel
brain volume changes (based on individual flow images).
Because spectra were acquired at long TE and short TR, and
relaxation time changes can not be entirely ruled out, these
adjusted percentages of metabolite change remain somewhat
semi-quantitative in nature. However, significant augmenta-
tion of cerebellar choline and frontomesial NAA levels
upon short-term sobriety found in this study is in good
accordance with previous longitudinal data (Bendszus et al.,
2001; Parks et al., 2001; Ende et al., 2005; Durazzo et al.,
2006) and substantiates evidence for neuronal and glial
regeneration. Reversal of brain shrinkage could, in theory,
be simulated by increased perfusion and intracranial
blood volume (Trabert et al., 1995) but such an explanation
would not be consistent with these spectroscopic data. Less
pronounced and more variable increases of frontomesial
choline and cerebellar NAA upon short-term abstinence may
in part be due to partial voluming with more white than
grey matter covered by cerebellar SVS and the reverse for
frontomesial spectroscopy voxels. This notion is supported
by consistently higher cerebellar choline levels compared
with frontomesial SVS whereas NAA levels were comparable
in the infra- and supratentorial voxels (data not shown),
possibly also due to high neuronal density in the cerebellum.
On average, the percentage of supratentorial choline change
was lower than in the cerebellum whereas cerebellar NAA
showed a similar percentage change as in frontomesial loca-
tion but was just contaminated by higher variance (Table 1).
Thus, it may be argued that qualitative changes of choline
and NAA upon short-term abstinence from alcoholism seem
quite consistent on the infra- and supratentorial level
rendering these metabolites rather general markers of
recovery.
The lack of significant group differences between
patients and controls may be due to the sample size, less
severe metabolic brain damage of uncomplicated, not
heavily nicotine abusing alcoholics, or both. In any case, it
emphasizes the superior power of longitudinal as opposed to
cross-sectional comparisons. With regards to presumably
increased vulnerability of females to alcoholic brain damage
(Agartz et al., quoted in Mann et al., 2001, 2005), our data
did not reveal significant gender differences for metabolic or
morphological brain recovery upon short-term abstinence
from alcoholism. The latter is in accordance to recent data
(Mann et al., 2005) even though our sample size was rather
small with very few women included and no significant
gender difference for the duration of dependence. Thus, if
there is telescoping brain injury in females it may not be
easily reversible.
Longer duration of dependence may possibly, in
some cases, lead to less frontomesial NAA, cerebellar
choline, and global brain volume gains. Therefore,
prolonged alcoholism at least potentially constrains
metabolic as well as morphological brain recovery.
Schweinsburg et al. (2004) have reported that longer history
of active drinking is associated with more profound NAA
reduction. This finding could correspond to prolonged
alcoholism duration eventually limiting NAA restitution
upon sobriety.
Global brain volume gain upon sobriety was significantly
related to rising cerebellar and frontomesial choline but not
NAA levels when corrected for maximal conceivable local
brain volume changes within joint co-registered spectro-
scopy voxels. Thereby, our pilot evidence proposes that early
brain volume regain upon sobriety is primarily driven by a
cerebral choline increase which is supposed to indicate
recovery from white matter damage potentially consistent
with astrocytic regrowth and remyelination (Meyerhoff/
quoted in Mason et al., 2005) and which could, in some
instances, decrease the longer the illness. Since, in our
morphometric assessment, a spatial preference for early
brain regain has been delineated especially to periventricular
edges (Fig. 1), white matter restoration may in fact prevail
upon short-term abstinence of uncomplicated alcoholics.
NAA gains by abstinence were, on the other hand, below
cerebellar choline increase but, at least on the supratentorial
level, accompanied by cognitive improvement in the d2-test
of attention. Even though attention, concentration, and
performance speed changes upon abstinence may be linked
to learning effects (Mann et al., 1999), neuropsychological
improvement in this domain was, at an uncorrected
significance level, also related to morphological brain
regeneration. Nevertheless, the neuropsychological findings
of our study remain yet quite exploratory in nature as only
the d2-test of attention has been assessed longitudinally.
Slight NAA gains have been reported within the first week
upon correction of severe dehydration (Lee et al., 1994). For
our 6–7 week patient follow-up data, however, rehydration
is rather unlikely to be the primary mechanism involved.
Instead, our findings of unchanged cerebral water integrals,
creatine and myo-inositol concentrations as well as serum
electrolytes and RBC indices and of insignificant metabolite
differences between our patients and controls are in line with
the notion that early brain regain associated with abstinence
from alcoholism cannot be sufficiently explained by simple
rehydration. Furthermore, we did not observe a pathological
shift or reversal of the patients’ NAA/myo-inositol ratio
associated with severe dehydration (Lee et al., 1994). Because
myo-inositol presumably acts as an osmoregulator, this is
further evidence for an osmotic steady-state in our patient
(as well as control) sample. Thus, a reversal of more complex
metabolic dysfunctions and, for example, axonal volume
changes in cerebral white matter ought to contribute, at least
in part, to the choline and NAA changes observed
(De Stefano et al., 1995; Bjartmar et al., 2002). Notably,
rising NAA levels may not necessarily reflect axonal or
dendritic sprouting but also be related to (re-)myelination
(Burri et al., 1991; Urenjak et al., 1992), and even adult
human white matter harbours multipotential progenitor
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cells capable of neuro- as well as gliogenesis in vitro (Nunes
et al., 2003).
In summary, sobriety has marked and early, globally
averaged and regionally specific morphological, metabolic
as well as functional benefits for convalescent alcoholics.
Whether this is due to glial or neuronal viability or both
remains somewhat unclear but prolonged dependence might
possibly limit rapid recovery from white matter brain injury.
Elucidating the precise nature and cellular mechanisms of
this recovery further may serve as a valuable model of brain
regeneration and, in the future, become relevant for other
disorders with toxic insults of white matter, in particular.
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